Indivior Pharmaceuticals Inc
INDV
Rang in aandelen
#4003
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aandeelprijs
$32.56
Laatst gesynchroniseerd: 2026-10-16
Marktkapitalisatie
$4.06B
Verandering (1 dag)
-3.15%
Verandering (1 jaar)
33.01%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Categorie
Healthcare
EPS voor Indivior Pharmaceuticals Inc (INDV)
EPS per June 2026 TTM: $2.84
Volgens de laatste financiële rapporten en de aandelenkoers van Indivior Pharmaceuticals Inc is de huidige EPS van het bedrijf (TTM) $2.84. Eind 2023 had het bedrijf een EPS van $0.01, een stijging ten opzichte van de EPS van 2022 die $-0.37 bedroeg.
EPS-geschiedenis van Indivior Pharmaceuticals Inc van 2016 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
